395 related articles for article (PubMed ID: 32652144)
21. Titanium Dioxide Presents a Different Profile in Dextran Sodium Sulphate-Induced Experimental Colitis in Mice Lacking the IBD Risk Gene Ptpn2 in Myeloid Cells.
Conde J; Schwarzfischer M; Katkeviciute E; Häfliger J; Niechcial A; Brillant N; Manzini R; Bäbler K; Atrott K; Lang S; Scharl M
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466682
[TBL] [Abstract][Full Text] [Related]
22. Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease.
Chiriac MT; Buchen B; Wandersee A; Hundorfean G; Günther C; Bourjau Y; Doyle SE; Frey B; Ekici AB; Büttner C; Weigmann B; Atreya R; Wirtz S; Becker C; Siebler J; Neurath MF
Gastroenterology; 2017 Jul; 153(1):123-138.e8. PubMed ID: 28342759
[TBL] [Abstract][Full Text] [Related]
23. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation.
Welz PS; Wullaert A; Vlantis K; Kondylis V; Fernández-Majada V; Ermolaeva M; Kirsch P; Sterner-Kock A; van Loo G; Pasparakis M
Nature; 2011 Jul; 477(7364):330-4. PubMed ID: 21804564
[TBL] [Abstract][Full Text] [Related]
24. Protein tyrosine phosphatase N2 regulates TNFα-induced signalling and cytokine secretion in human intestinal epithelial cells.
Scharl M; McCole DF; Weber A; Vavricka SR; Frei P; Kellermeier S; Pesch T; Fried M; Rogler G
Gut; 2011 Feb; 60(2):189-97. PubMed ID: 21115548
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
26. High-Throughput Screen Identifies Host and Microbiota Regulators of Intestinal Barrier Function.
Grosheva I; Zheng D; Levy M; Polansky O; Lichtenstein A; Golani O; Dori-Bachash M; Moresi C; Shapiro H; Del Mare-Roumani S; Valdes-Mas R; He Y; Karbi H; Chen M; Harmelin A; Straussman R; Yissachar N; Elinav E; Geiger B
Gastroenterology; 2020 Nov; 159(5):1807-1823. PubMed ID: 32653496
[TBL] [Abstract][Full Text] [Related]
27. The autoimmune susceptibility gene,
Shawki A; Ramirez R; Spalinger MR; Ruegger PM; Sayoc-Becerra A; Santos AN; Chatterjee P; Canale V; Mitchell JD; Macbeth JC; Gries CM; Tremblay ML; Hsiao A; Borneman J; McCole DF
Gut Microbes; 2020 Nov; 11(6):1547-1566. PubMed ID: 32586195
[TBL] [Abstract][Full Text] [Related]
28. Anti-Inflammatory and Barrier-Stabilising Effects of Myrrh, Coffee Charcoal and Chamomile Flower Extract in a Co-Culture Cell Model of the Intestinal Mucosa.
Weber L; Kuck K; Jürgenliemk G; Heilmann J; Lipowicz B; Vissiennon C
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32664498
[TBL] [Abstract][Full Text] [Related]
29. The Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor 2 Axis in Intestinal Epithelial Cells Regulates Intestinal Barrier Function During Intestinal Epithelial Cells-CD4+T-Cell Interactions.
Chen T; Lin R; Jin S; Chen R; Xue H; Ye H; Huang Z
Cell Physiol Biochem; 2018; 48(3):1188-1200. PubMed ID: 30045015
[TBL] [Abstract][Full Text] [Related]
30. T cell protein tyrosine phosphatase prevents STAT1 induction of claudin-2 expression in intestinal epithelial cells.
Krishnan M; McCole DF
Ann N Y Acad Sci; 2017 Oct; 1405(1):116-130. PubMed ID: 28804910
[TBL] [Abstract][Full Text] [Related]
31. Loss of protein tyrosine phosphatase non-receptor type 2 reduces IL-4-driven alternative macrophage activation.
Spalinger MR; Crawford M; Bobardt SD; Li J; Sayoc-Becerra A; Santos AN; Shawki A; Chatterjee P; Nair MG; McCole DF
Mucosal Immunol; 2022 Jan; 15(1):74-83. PubMed ID: 34420044
[TBL] [Abstract][Full Text] [Related]
32. Activation of protein tyrosine phosphatase non-receptor type 2 by spermidine exerts anti-inflammatory effects in human THP-1 monocytes and in a mouse model of acute colitis.
Morón B; Spalinger M; Kasper S; Atrott K; Frey-Wagner I; Fried M; McCole DF; Rogler G; Scharl M
PLoS One; 2013; 8(9):e73703. PubMed ID: 24040033
[TBL] [Abstract][Full Text] [Related]
33. Targeting uPA-uPAR interaction to improve intestinal epithelial barrier integrity in inflammatory bowel disease.
Cheng Y; Hall TR; Xu X; Yung I; Souza D; Zheng J; Schiele F; Hoffmann M; Mbow ML; Garnett JP; Li J
EBioMedicine; 2022 Jan; 75():103758. PubMed ID: 34933179
[TBL] [Abstract][Full Text] [Related]
34. Increased Expression of DUOX2 Is an Epithelial Response to Mucosal Dysbiosis Required for Immune Homeostasis in Mouse Intestine.
Grasberger H; Gao J; Nagao-Kitamoto H; Kitamoto S; Zhang M; Kamada N; Eaton KA; El-Zaatari M; Shreiner AB; Merchant JL; Owyang C; Kao JY
Gastroenterology; 2015 Dec; 149(7):1849-59. PubMed ID: 26261005
[TBL] [Abstract][Full Text] [Related]
35. The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction.
Sayoc-Becerra A; Krishnan M; Fan S; Jimenez J; Hernandez R; Gibson K; Preciado R; Butt G; McCole DF
Inflamm Bowel Dis; 2020 Feb; 26(3):407-422. PubMed ID: 31751457
[TBL] [Abstract][Full Text] [Related]
36. Differential effect of immune cells on non-pathogenic Gram-negative bacteria-induced nuclear factor-kappaB activation and pro-inflammatory gene expression in intestinal epithelial cells.
Haller D; Holt L; Parlesak A; Zanga J; Bäuerlein A; Sartor RB; Jobin C
Immunology; 2004 Jun; 112(2):310-20. PubMed ID: 15147574
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological activation of ERβ by arctigenin maintains the integrity of intestinal epithelial barrier in inflammatory bowel diseases.
Tao Y; Yue M; Lv C; Yun X; Qiao S; Fang Y; Wei Z; Xia Y; Dai Y
FASEB J; 2020 Feb; 34(2):3069-3090. PubMed ID: 31908053
[TBL] [Abstract][Full Text] [Related]
38. Development of an Inflammation-Triggered In Vitro "Leaky Gut" Model Using Caco-2/HT29-MTX-E12 Combined with Macrophage-like THP-1 Cells or Primary Human-Derived Macrophages.
Le NPK; Altenburger MJ; Lamy E
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108590
[TBL] [Abstract][Full Text] [Related]
39. NOX4 promotes mucosal barrier injury in inflammatory bowel disease by mediating macrophages M1 polarization through ROS.
Han C; Sheng Y; Wang J; Zhou X; Li W; Zhang C; Guo L; Yang Y
Int Immunopharmacol; 2022 Mar; 104():108361. PubMed ID: 34949550
[TBL] [Abstract][Full Text] [Related]
40. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice.
Zhao H; Zhang H; Wu H; Li H; Liu L; Guo J; Li C; Shih DQ; Zhang X
BMC Gastroenterol; 2012 May; 12():57. PubMed ID: 22647055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
